Description
This multi-peptide complex combines the angiogenic fragment BPC-157 with the actin-sequestering protein TB-500 to investigate bidirectional tissue remodeling synergy. It serves as a specialized reagent for exploring the concurrent activation of the VEGFR2 pathway and G-actin buffer systems in complex wound-healing assays. For research use only.
- Dual-Pathway Angiomodulation: Investigated for the combined effect of collateral vessel recruitment and endothelial cell migration via the VEGFR2-Akt-eNOS axis.
- Fibroblast & Collagen Kinetics: Studied for the coordinated enhancement of FAK-paxillin signaling and matrix deposition in connective tissue repair models.
- Synergistic Anti-Inflammatory Action: Explored for concurrent NO system modulation (BPC-157) and NF-κB suppression (TB-500) in acute and chronic inflammation research models.









Reviews
There are no reviews yet.